Abstract
Introduction
Obesity is one of the leading public health concerns with over half a million Americans being classified as obese and almost two billion classified as overweight. This has an impact on overall health of the individual, with increased comorbidities and premature death, as well as increased economic cost. This study evaluates the weight loss of patients with limited societal support and resources cared for at a single bariatric center of excellence, The Center for Surgical Weight Control, in Cabell County, West Virginia.
Methods
Retrospective review of patients that have undergone either a Vertical Sleeve Gastrectomy (VSG) or a Roux-en-Y gastric bypass (RNYGB) between the years of 2017 and 2018 At the Center for Surgical Weight Control. Weight loss was evaluated at 6 months, 1 year, and 2 years.
Results
There were 290 patients between 2017 and 2018. On average, the VSG group lost 46% of excess body weight (EBW) at 6 months, 57% of EBW at 1 year, and 61% of EBW at 2 years. In the RNYGB group patients lost on average 54% of EBW at 6 months, 65% of EBW at 1 year, and 88% of EBW at 2 years.
Discussion
A loss of 5–15% of EBW can improve obesity-related comorbidities. These comorbidities include diabetes, hypertension, hyperlipidemia, gastroesophageal reflux disease, and obstructive sleep apnea. Improvement in these comorbidities not only benefits each patient individually, but will also help improve the effects on society as a whole.
Conclusion
Obesity is a debilitating and deadly disease, thus makes it very important to address in order to reduce burden on both patients and society as a whole. There is an expected amount of weight loss a patient should have depending on the type of surgery they undergo. Our patients were successful at meeting and exceeding the expected percentage of EBW loss after both VSG and RNYGB.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gudbrandsen OA, Dankel SN, Skumsnes L et al (2019) Short-term effects of Vertical sleeve gastrectomy and Roux-en-Y gastric bypass on glucose homeostasis. Sci Rep. https://doi.org/10.1038/s41598-019-51347-x
Ballsmider LA, Vaughn AC, David M, Hajnal A, Di Lorenzo PM, Czaja K (2015) Sleeve gastrectomy and Roux-en-Y gastric bypass alter the gut-brain communication. Neural Plast 2015:1–9. https://doi.org/10.1155/2015/601985
Barry RG, Amiri FA, Gress TW, Nease DB, Canterbury TD (2017) Laparoscopic vertical sleeve gastrectomy: a 5-year veterans affairs review. Medicine 96(35):e7508. https://doi.org/10.1097/MD.0000000000007508
Pucci A, Batterham RL (2019) Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different. J Endocrinol Invest 42(2):117–128. https://doi.org/10.1007/s40618-018-0892-2
Porter D (2002) Obesity: facts, figures, guidelines. Department of Health and Human Resources, West Virginia Health Statistic Center (HSC)
Arble DM, Sandoval DA, Turek FW, Woods SC, Seeley RJ (2015) Metabolic effects of bariatric surgery in mouse models of circadian disruption. Int J Obes 39(8):1310–1318. https://doi.org/10.1038/ijo.2015.54
Fuchs T, Loureiro M, Both GH, Skraba HH, Costa-Casagrande TA (2017) The role of the sleeve gastrectomy and the management of type 2 diabetes. ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 30(4):283–286. https://doi.org/10.1590/0102-6720201700040013
The Robert Wood Johnson Foundation. The State of Childhood Obesity. 2020. State Obesity Data. Available at: <https://stateofchildhoodobesity.org/states/wv. Accessed May 20, 2020.
Cummings BP, Bettaieb A, Graham JL et al (2012) Vertical sleeve gastrectomy improves glucose and lipid metabolism and delays diabetes onset in UCD-T2DM rats. Endocrinology 153(8):3620–3632. https://doi.org/10.1210/en.2012-1131
Cutolo PP, Nosso G, Vitolo G, Brancato V, Capaldo B, Angrisani L (2012) Clinical efficacy of laparoscopic sleeve gastrectomy vs laparoscopic gastric bypass in obese type 2 diabetic patients: a retrospective comparison. Obes Surg 22(10):1535–1539. https://doi.org/10.1007/s11695-012-0657-5
Douros JD, Niu J, Sdao SM et al (2019) Sleeve gastrectomy rapidly enhances islet function independently of body weight. JCI Insight. https://doi.org/10.1172/jci.insight.126688
Salminen P, Helmiö M, Ovaska J et al (2018) Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial. JAMA 319(3):241. https://doi.org/10.1001/jama.2017.20313
Wilson-Perez HE, Chambers AP, Ryan KK et al (2013) Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like peptide 1 receptor deficiency. Diabetes 62(7):2380–2385. https://doi.org/10.2337/db12-1498
Wood L, Roelofs K, Koch LG, Britton SL, Sandoval DA (2018) Vertical sleeve gastrectomy corrects metabolic perturbations in a low-exercise capacity rat model. Mol Metab 11:189–196. https://doi.org/10.1016/j.molmet.2018.02.009
Douros JD, Lewis AG, Smith EP et al (2018) Enhanced glucose control following vertical sleeve gastrectomy does not require a b-Cell glucagon-like peptide 1 receptor. Metabolism 67(8):1504–1511. https://doi.org/10.2337/db18-0081
McGavigan AK, Henseler ZM, Garibay D et al (2017) Vertical sleeve gastrectomy reduces blood pressure and hypothalamic endoplasmic reticulum stress in mice. Dis Model Mech 10(3):235–243. https://doi.org/10.1242/dmm.027474
Campos J, Ramos A, Szego T, Zilberstein B, Feitosa H, Cohen R (2016) The role of metabolic surgery for patients with obesity grade I and type 2 diabetes not controlled clinically. ABCD Arquivos Brasileiros de Cirurgia Digestiva (São Paulo) 29(suppl 1):102–106. https://doi.org/10.1590/0102-6720201600s10025
Ding L, Sousa KM, Jin L et al (2016) Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice: vertical Sleeve Gastrectomy Activates GPBAR-1/TGR5. Hepatology 64(3):760–773. https://doi.org/10.1002/hep.28689
Douros JD, Niu J, Sdao S et al (2019) Temporal plasticity of insulin and incretin secretion and insulin sensitivity following sleeve gastrectomy contribute to sustained improvements in glucose control. Mol Metab 28:144–150. https://doi.org/10.1016/j.molmet.2019.07.003
Gu J, Vergis A (2020) Diabetes improvement and bariatric surgery—review of laparoscopic Roux-en-Y gastric bypass vs. laparoscopic vertical sleeve gastrectomy. Ann Transl Med 8(S1):S10–S10. https://doi.org/10.21037/atm.2020.01.47
Peterli R, Wölnerhanssen BK, Peters T et al (2018) Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial. JAMA 319(3):255. https://doi.org/10.1001/jama.2017.20897
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
Doctor Jenalee Corsello, Doctor Ruth Gerola, medical student Mercy Babatope, Doctor Semeret Munie, and Doctor D. Blaine Nease, do not have any conflicts of interest or financial ties to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Corsello, J., Gerola, R., Babatope, M. et al. Do bariatric patient’s in rural areas achieve comparative weight loss as national average? single center experience in appalachia west virginia. Surg Endosc 36, 8515–8519 (2022). https://doi.org/10.1007/s00464-022-09541-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-022-09541-y